Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001140361-18-019365
Filing Date
2018-04-24
Accepted
2018-04-24 15:56:31
Documents
1
Effectiveness Date
2018-04-24
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 14665
  Complete submission text file 0001140361-18-019365.txt   15939
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: D/A | Act: 33 | File No.: 021-305792 | Film No.: 18771416
SIC: 2834 Pharmaceutical Preparations